Adagio Medical Holdings (ADGM) Cost of Revenue (2023 - 2025)

Name: Adagio Medical Holdings (ADGM) Cost of Revenue (2023 - 2025) | Business Quant
Creator: Business Quant

Adagio Medical Holdings (ADGM) reported Cost of Revenue of $58000.0 for Q4 2025, up 87.1% on a QoQ basis from $31000.0 in Q3 2025.

Adagio Medical Holdings (ADGM) has 3 years of Cost of Revenue data on file, last reported at $58000.0 in Q4 2025.

Quarterly Cost of Revenue changed N/A year-over-year to $58000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $684000.0 (changed N/A YoY) and the FY2025 annual result came in at $684000.0, down 64.69% from the prior year.
Cost of Revenue improved to $58000.0 in Q4 2025 per ADGM's latest filing, from $31000.0 in the prior quarter.
Across five years, Cost of Revenue topped out at $682000.0 in Q2 2024 and bottomed at $31000.0 in Q3 2025.
The 3-year median for Cost of Revenue is $334000.0 (2023), against an average of $323222.2.
The widest annual swing landed in 2024, when Cost of Revenue soared 63.64%; it then tumbled 92.51% in 2025.
Tracing ADGM's Cost of Revenue over 3 years: stood at $334000.0 in 2023, then increased by 23.95% to $414000.0 in 2024, then plunged by 85.99% to $58000.0 in 2025.
Per Business Quant, the three latest ADGM Cost of Revenue figures stand at $58000.0 (Q4 2025), $31000.0 (Q3 2025), and $342000.0 (Q2 2025).

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cost of Rev (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	4.89 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	2.21 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	3.26 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	1.59 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	362.60 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	2.51 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	441.60 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	481.00 Mn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	891.20 Mn
10	Adagio Medical Holdings	16.86 Mn	3.95 Mn	-	-

Download Data 🔒